Charles River and Medigen Advance Vaccine Development With NGS
Wilmington, Massachusetts, August 20, 2026 Charles River Laboratories International and Medigen Vaccine Biologics Corp. (MVC) have entered into a...
regulatory readiness
Advertisement
HeartX Opens Applications for 2026 Cardio Accelerator
Houston, Texas | January 2026 — HeartX, a leading cardiovascular innovation accelerator, has officially opened applications for its 2026...
AI Grant Aims to Boost Biologics Developability at Just – Evotec
SAN DIEGO | January 8, 2026 — Just – Evotec Biologics, a collaboration between Evotec SE and Just –...
Illinois Grant Fuels Helix 51 Cancer Drug Development
ROCKFORD, Illinois | January 8, 2026 — A Helix 51 incubator company based at RFU (Rockford, IL) has received...
Advertisement
